Regulations.gov document
Determinations That Drugs Were Not Withdrawn from Sale for Reasons of Safety or…
Notice · FDA-2011-P-0025 · posted May 1, 2012
Key facts
| Document ID | FDA-2011-P-0025-0004 |
|---|---|
| Title | Determinations That Drugs Were Not Withdrawn from Sale for Reasons of Safety or Effectiveness: GRIFULVIN V (Griseofulvin Microcrystalline) Tablets, 250 Milligrams |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2011-P-0025 |
| Posted | May 1, 2012 |
| Federal Register citation | 77 FR 25720 |
| FR document number | 2012-10466 |
| Comment period opens | May 1, 2012 |
| Effective date | May 1, 2012 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: